STOCK TITAN

Transcat SEC Filings

TRNS NASDAQ

Welcome to our dedicated page for Transcat SEC filings (Ticker: TRNS), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.

This page provides access to U.S. Securities and Exchange Commission filings for Transcat Inc (Nasdaq: TRNS), a provider of accredited calibration services, cost control and optimization services, and distribution and rental of professional grade handheld test, measurement, and control instrumentation. These regulatory documents offer detailed insight into Transcat’s operations, governance, and financial condition.

Through its periodic reports such as the Form 10-K and Form 10-Q (not reproduced here), Transcat describes its two operating segments—Service and Distribution—its focus on highly regulated industries including Life Science, aerospace and defense, energy and utilities, and industrial manufacturing, and the risks and opportunities associated with its calibration and distribution activities.

Current reports on Form 8-K are particularly relevant for tracking material events. Recent 8-K filings have disclosed the completion of the Essco Calibration Laboratory acquisition, entry into a new five-year $150 million secured revolving credit facility, quarterly earnings releases, executive leadership changes, and a CEO transition agreement. Other 8-Ks detail equity retention awards for certain executive officers and the appointment or retirement of key finance and board personnel.

Transcat’s proxy statement on Form DEF 14A outlines its board structure, committee composition, Corporate Governance Guidelines, executive compensation programs, and matters submitted to shareholder votes, such as director elections, say-on-pay, and auditor ratification. The proxy materials also summarize the company’s description of its business and strategic priorities, including its acquisition strategy.

On Stock Titan, investors can use AI-powered tools to quickly interpret these filings, with summaries that highlight items such as segment definitions, acquisition terms, credit facility covenants, and compensation arrangements. Filings related to executive equity awards, succession planning, and shareholder meeting results are especially useful for understanding how Transcat’s governance and capital allocation decisions may relate to TRNS stock.

Rhea-AI Summary

Robert Mecca, a director of Transcat Inc. (TRNS), reported equity award activity on 09/10/2025 and 09/11/2025. On 09/10/2025 the filing shows restricted stock units (RSUs) granted totaling 1,587 RSUs that convert one-for-one into common stock and, per the award terms, generally vest on September 10, 2026. On 09/11/2025 a separate tranche of 704 RSUs is reported as vested, converting into common stock. The filing also discloses a stock option covering 10,000 shares with an exercise price of $98.88 and an expiration date of January 24, 2034; this option vests pro rata over five years. The form is signed by an attorney-in-fact on behalf of Mr. Mecca on September 11, 2025. The disclosure is limited to these award and vesting events and does not include earnings, cash transactions, or other operational details.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

Transcat Inc. (TRNS) director Mbago M. Kaniki received equity awards and holds an option position. The filing reports conversion-eligible restricted stock units (RSUs) that convert one-for-one into common stock. RSUs granted 09/10/2025 total 1,587 shares and vest on 09/10/2026. An additional 704 RSUs vested and converted on 09/11/2025, increasing beneficial ownership by 704 shares. The reporting person also holds a stock option to buy 10,000 shares at $47.14 per share exercisable on a pro rata vesting schedule through 05/12/2031. After the reported transactions, the filer directly beneficially owns 2,593 shares.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

Gary J. Haseley, a director of Transcat Inc. (TRNS), reported equity changes arising from restricted stock unit (RSU) activity in September 2025. On September 11, 2025 704 shares were acquired following RSU vesting at no cash cost. Following that transaction, Mr. Haseley held 39,102 shares directly. The filing also shows 1,200 shares held indirectly through family trusts.

Separately, on September 10, 2025 he received an award of 1,587 RSUs granted under a Rule 16b-3 exempt transaction; those RSUs vest on September 10, 2026 and convert one-for-one to common stock when vested. The filing is a routine Section 16 disclosure documenting vesting and a new RSU grant.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
Rhea-AI Summary

Christopher P. Gillette, a director of Transcat Inc. (TRNS), reported changes in his beneficial ownership on Form 4. The filing shows 704 shares were acquired on 09/11/2025 through the vesting of restricted stock units (RSUs) and are reported with a $0 per-share conversion value. The document also discloses an earlier RSU grant of 1,587 RSUs dated 09/10/2025 that convert one-for-one to common stock and generally vest on 09/10/2026. In addition, Mr. Gillette holds a stock option covering 10,000 shares with an exercise price of $109.55 and pro rata vesting over five years. The filing was signed by an attorney-in-fact on behalf of Mr. Gillette on 09/11/2025.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

Reporting person: Dawn DePerrior, a director of Transcat, Inc. (TRNS). The Form 4 discloses equity awards and option activity reported for transactions on September 10-11, 2025. On 09/10/2025 Ms. DePerrior was awarded 1,587 restricted stock units (RSUs) that convert one-for-one into common shares and vest on 09/10/2026. On 09/11/2025 704 RSUs vested and converted into 704 shares of common stock, increasing her beneficial ownership by that amount. Also reported is a stock option to purchase 10,000 shares at an exercise price of $92.92 that vests pro rata over five years from the grant date and expires 10/26/2033. All reported holdings are direct.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

Transcat Inc (TRNS) director Oksana S. Dominach reported equity transactions on Form 4 reflecting restricted stock unit (RSU) activity and an outstanding stock option. On 09/11/2025, 704 RSUs were reported as acquired under transaction code M and converted into common stock at no cash price; 1,587 RSUs were reported as acquired on 09/10/2025 but vest on 09/10/2026 per the award terms. The filing also shows a fully vested stock option to purchase 10,000 shares at $26.27 expiring 10/22/2029. Following the reported transactions, Dominach beneficially owns 4,346 shares.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
Rhea-AI Summary

Craig D. Cairns, a director of Transcat Inc. (TRNS), reported changes in his beneficial ownership. The filing shows restricted stock units (RSUs) converting to common stock on a one-for-one basis, with 1,587 RSUs reported as acquired on 09/10/2025 and shown as 1,587 shares beneficially owned directly. An additional 704 RSUs are reported with transaction code M on 09/11/2025. Following the reported transactions, Mr. Cairns directly beneficially owns 5,003 shares of common stock and holds a stock option for 10,000 shares with a $47.14 exercise price exercisable pro rata through 05/12/2031. He also has indirect holdings via the Howe & Rusling 401(k) plan (430 shares) and Roth 401(k) plan (1,910 shares). The filing was signed by an attorney-in-fact on Mr. Cairns' behalf.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

Transcat, Inc. (TRNS) reporting person Cynthia Langston, a director, recorded equity award activity on Form 4. On 09/11/2025 Ms. Langston was reported to have acquired 704 shares through vesting or conversion of restricted stock units at $0 per share and continues to beneficially own 1,837 shares of common stock directly after the reported transactions. A prior grant of 1,587 RSUs (granted 09/10/2025) was noted as exempt under Rule 16b-3 and generally vests on 09/10/2026, while 1,587 RSUs vested on 09/10/2025 and converted one-for-one into common shares. Additionally, a stock option covering 10,000 shares with an exercise price of $73.80 and a five-year pro rata vesting schedule was reported.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

Kristina L. Johnston, Principal Accounting Officer of Transcat, Inc. (TRNS), reports beneficial ownership of 358 restricted stock units (RSUs) awarded under the Transcat, Inc. 2021 Stock Incentive Plan. Each RSU converts into one share of common stock on a one-for-one basis and, unless noted otherwise in the award, vests on March 25, 2028. The statement indicates direct ownership of these RSUs.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
Rhea-AI Summary

Transcat, Inc. reported that effective September 10, 2025, Kristina Johnston, age 48, was appointed as principal accounting officer, following the planned retirement of prior principal accounting officer Scott D. Deverell. She has served as the Company’s controller since June 2025 and previously was Chief Financial Officer of Vintage Wine Estates, Inc. from March 2022 to December 2025 and held finance leadership roles at Constellation Brands, Inc. from 2018 to 2022.

Johnston’s annual base salary will be $250,000, with a target performance-based cash incentive of 30% of base salary and a target long-term equity incentive opportunity of 25% of base salary, plus participation in standard benefits. At the September 10, 2025 annual meeting, shareholders re-elected three directors with over 7.7 million votes each, approved executive compensation, and indicated a preference for holding advisory votes on executive pay every 1 year, which the Board adopted, with the next frequency vote to occur no later than the 2031 annual meeting.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
current report

FAQ

How many Transcat (TRNS) SEC filings are available on StockTitan?

StockTitan tracks 40 SEC filings for Transcat (TRNS), including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, and Form 4 insider trading disclosures. Each filing includes AI-generated summaries, impact scoring, and sentiment analysis.

When was the most recent SEC filing for Transcat (TRNS)?

The most recent SEC filing for Transcat (TRNS) was filed on September 11, 2025.